Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB12341InvestigationalSmall molecule
Aticaprant has been used in trials studying the health services research and basic science of Anxiety Disorders and Alcohol Dependence.
- Mechanism
- Curator reviewed
Pharmacologically active on Kappa-type opioid receptor
- Formula / weight
- C26H27FN2O2 · 418.512 g/mol (avg)
- Also known as
- BENZAMIDE, 4-(4-(((2S)-2-(3,5-DIMETHYLPHENYL)-1-PYRROLIDINYL)METHYL)PHENOXY)-3-FLUORO-
- Code names
- CERC-501 · JNJ-67953964 · JSPA-0658 · LY-2456302
Resolves to
Structure
InChIKey
ZHPMYDSXGRRERG-DEOSSOPVSA-NSMILESCC1=CC(=CC(C)=C1)[C@@H]1CCCN1CC1=CC=C(OC2=CC=C(C=C2F)C(N)=O)C=C1Targets
What you can answer from here — as of June 15, 2026
Which drugs share a target with Aticaprant, and which of those have an active Phase 3 trial?